Raynaud's Phenomenon After Chemotherapy for Testicular Cancer
Author Information
Author(s): M. Skard Heierl, T. Nilsen, V. Graver, N. Aass, S.D. Fossa
Primary Institution: Ullevail University Hospital and The Norwegian Radium Hospital, Oslo, Norway
Hypothesis
The study aims to clarify the pathophysiology of Raynaud's phenomenon in patients treated with combination chemotherapy for testicular cancer.
Conclusion
The study found that patients exhibited an exaggerated and prolonged vasoconstrictor response to cold, characteristic of Raynaud's phenomenon after chemotherapy.
Supporting Evidence
- All patients showed a mean flux reduction of 61% after cold provocation.
- Normal controls had a mean flux reduction of 24% and a restitution time of 1.5 min.
- Five out of eight patients exhibited mild polyneuropathy.
Takeaway
Some people who had chemotherapy for testicular cancer developed a condition called Raynaud's phenomenon, which makes their fingers react strongly to cold.
Methodology
Peripheral circulation was measured using laser Doppler flowmetry before and after cold provocation in patients treated with chemotherapy.
Limitations
The small sample size limits the ability to make broad conclusions.
Participant Demographics
Patients were previously treated for testicular cancer, with a mean age of 41 years.
Want to read the original?
Access the complete publication on the publisher's website